FOXO3 and kidney disorder: In an experimental model of TAC-induced nephropathy, we found that concomitant Klotho treatment inhibits the PI3K/AKT-mediated phosphorylation of FoxO3a and enhances FoxO3a binding to the MnSOD promoter.